Biotech And Specialty Pharma’s M&A Power Gains On Big Pharma, EY Report
This article was originally published in The Pink Sheet Daily
Executive Summary
Big pharma continues to have the most buying power, according to EY’s annual M&A report, but the buying power of big biotech and specialty pharma grew significantly more.